Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 421

1.

Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients.

Gerna G, Lilleri D, Rognoni V, Agozzino M, Meloni F, Oggionni T, Pellegrini C, Arbustini E, D'Armini AM.

Am J Transplant. 2009 May;9(5):1142-50. doi: 10.1111/j.1600-6143.2009.02616.x.

2.

Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation.

Gerna G, Lilleri D, Chiesa A, Zelini P, Furione M, Comolli G, Pellegrini C, Sarchi E, Migotto C, Bonora MR, Meloni F, Arbustini E.

Am J Transplant. 2011 Nov;11(11):2463-71. doi: 10.1111/j.1600-6143.2011.03636.x.

3.

Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation.

Gerna G, Lilleri D, Fornara C, Comolli G, Lozza L, Campana C, Pellegrini C, Meloni F, Rampino T.

Am J Transplant. 2006 Oct;6(10):2356-64.

4.

Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.

Lilleri D, Zelini P, Fornara C, Comolli G, Revello MG, Gerna G.

Clin Immunol. 2009 Jun;131(3):395-403. doi: 10.1016/j.clim.2009.02.002.

PMID:
19268633
5.

Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.

Gerna G, Baldanti F, Torsellini M, Minoli L, ViganĂ² M, Oggionnis T, Rampino T, Castiglioni B, Goglio A, Colledan M, Mammana C, Nozza F, Daniele L; Bergamo Transplant Group..

Antivir Ther. 2007;12(1):63-72.

PMID:
17503749
8.

Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients.

Gerna G, Lilleri D, Furione M, Castiglioni B, Meloni F, Rampino T, Agozzino M, Arbustini E.

New Microbiol. 2012 Jul;35(3):279-87.

9.

Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.

Lilleri D, Baldanti F, Gatti M, Rovida F, Dossena L, De Grazia S, Torsellini M, Gerna G.

J Med Virol. 2004 Jul;73(3):412-8.

PMID:
15170637
10.

Persistent cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients.

Shlobin OA, West EE, Lechtzin N, Miller SM, Borja M, Orens JB, Dropulic LK, McDyer JF.

J Immunol. 2006 Feb 15;176(4):2625-34.

11.

Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.

Lilleri D, Fornara C, Chiesa A, Caldera D, Alessandrino EP, Gerna G.

Haematologica. 2008 Feb;93(2):248-56. doi: 10.3324/haematol.11912.

12.

Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients.

Lilleri D, Gerna G, Bruno F, Draghi P, Gabanti E, Fornara C, Meloni F.

New Microbiol. 2013 Jul;36(3):267-77.

13.
14.

Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapy.

Brestrich G, Zwinger S, Roemhild A, Noutsias M, Rohde M, Keeren K, Sawitzki B, Volk HD, Reinke P, Hammer MH.

J Immunother. 2009 Nov-Dec;32(9):932-40. doi: 10.1097/CJI.0b013e3181b88fda.

PMID:
19816188
15.

Detection of human cytomegalovirus-specific T lymphocytes in human blood: comparison of two methods.

Schermann CM, Fischer G, Witt V, Kurz M, Potschger U, Fritsch G.

Cytotherapy. 2008;10(8):834-41. doi: 10.1080/14653240802474315.

PMID:
19016371
16.

Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation.

Ludwig B, Kraus FB, Kipp M, Preiser W, Schwerdtfeger R, Doerr HW, Buxbaum S.

J Clin Virol. 2006 Feb;35(2):160-6.

PMID:
16112610
17.
18.

Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.

Sacre K, Nguyen S, Deback C, Carcelain G, Vernant JP, Leblond V, Autran B, Dhedin N.

J Virol. 2008 Oct;82(20):10143-52. doi: 10.1128/JVI.00688-08.

19.
20.

Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation.

Lilleri D, Gerna G, Fornara C, Chiesa A, Comolli G, Zecca M, Locatelli F.

J Infect Dis. 2009 Mar 15;199(6):829-36. doi: 10.1086/597123.

Items per page

Supplemental Content

Support Center